To evaluate the effect of central venous catheter (CVC) removal on the outcome of patients with candidemia.
Methods of synthesis
How were the studies combined? A narrative synthesis was undertaken.
How were differences between studies investigated?
The differences in the results of the included studies were explored by examining differences in the patient populations, illness severity and inclusion criteria.
Results of the review
Four studies (n=864) were included: 2 prospective cohort (n=199) and 2 retrospective studies (n=665).
The four studies yielded conflicting results. Only one study showed a clear benefit from CVC removal in a subset of 21 neutropenic patients; another study showed no benefit, while the remaining two showed that this strategy had a marginal benefit.
In the first study, an analysis of the influence of CVC management on the prognosis was performed in 75 patients who had both a CVC in place and Karnofsky scale evaluated. The median performance status score was significantly higher in patients who had the catheter removed (40 versus 30; p=0.002), and catheter retention was the only variable associated with an increased risk of death on multivariate analysis (OR 4.22, 95% CI: 2.0, 11.6). However, in a subsequent analysis (authors' unpublished data), it was observed that in patients who received antifungal treatment, catheter removal was only associated with a lower mortality rate in the 21 patients with neutropenia (OR 15, 95% CI: 1.16, 316.66 ). This variable was not significant in the 52 patients without neutropenia (OR 1.94, 95% CI: 0.53, 7.19).
In the second study, a multivariate analysis found that catheter retention was not significantly associated with death. However, severity of illness (OR 46.6, 95% CI: 6.33, 861), persistent neutropenia (OR 33.1, 95% CI: 2.2, 498) and older age (OR 1.06 for each additional year, 95% CI: 1.10, 1.11) were.
The third study was undertaken to specifically identify predictors of poor outcome. The CVC exchange was associated with a higher cure rate, and earlier exchanges had greater effects. However, the patients who retained the catheters had significantly higher APACHE III scores (p<0.001) and were more likely to have neutropenia (p<0.001). Multivariate analysis found severity of illness (OR 1.05 per additional point, 95% CI: 1.03, 1.07), visceral dissemination (OR 6.0, 95% CI: 3.3, 11), persistent neutropenia (OR 11, 95% CI: 4.6, 24) , and treatment with antifungal therapy (OR 0.21, 95% CI: 0.09, 0.50) to be important predictors of death. In the subgroup of patients who had CVCs, full exchange of the catheter had a marginally beneficial effect (OR 2.0, 95% CI: 1.4, 2.9, p=0.06).
In the last study, catheter removal had a modest impact on mortality according to the multivariate analysis (OR 0.62, 95% CI: 0.38, 0.99, p=0.047) but not the univariate analysis. The other significant variables were the duration of positive blood cultures (OR 1.06, 95% CI: 1.01, 1.12), receipt of adequate antifungal treatment (OR 0.52, 95% CI: 0.32, 0.84), and hospitalisation ward (the OR for worse prognosis in intensive care units compared with surgical and medical wards was 2.06, 95% CI: 1.21, 3.51).
